자간전증 진단약 시장 규모, 점유율, 성장 분석 : 검사 유형별, 제품별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Preeclampsia Diagnostics Market Size, Share, and Growth Analysis, By Test Type (Blood Tests, Urine Analysis), By Product (Instruments, Consumables), By End-user, By Region - Industry Forecast 2025-2032
상품코드:1663073
리서치사:SkyQuest Technology Consulting Pvt. Ltd.
발행일:2025년 02월
페이지 정보:영문 219 Pages
라이선스 & 가격 (부가세 별도)
한글목차
자간전증 진단약 시장 규모는 2023년에 10억 9,000만 달러로 평가되며, 2024년 11억 2,000만 달러에서 2032년에는 14억 3,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 3.1%로 성장할 전망입니다.
세계 자간전증 진단제 시장은 임산부 건강에 대한 인식 증가와 임신 관련 합병증의 복잡성에 힘입어 크게 성장하고 있습니다. 심각한 고혈압성 질환인 자간전증은 산과 의료에 큰 위험을 초래하므로 정확한 조기 진단법에 대한 수요가 증가하고 있습니다. 이에 따라 주요 시장 참여자들은 조기 발견 및 조기 관리 개선을 위한 진단 기술 혁신을 추진하고 있습니다. 의료비 증가, 신흥 시장의 의료 인프라 강화, 산부인과 의료에 대한 첨단 의료 기술 도입 등의 요인이 시장 확대를 더욱 촉진하고 있습니다. 그러나 고가의 첨단 진단법 비용과 일부 지역에서는 의료 접근성이 제한적이라는 점이 문제점으로 지적되고 있습니다. 새로운 바이오마커와 비침습적 진단법에 대한 연구가 진행됨에 따라 시장은 당분간 지속적인 발전을 이룰 것으로 보입니다.
Preeclampsia Diagnostics Market size was valued at USD 1.09 billion in 2023 and is poised to grow from USD 1.12 billion in 2024 to USD 1.43 billion by 2032, growing at a CAGR of 3.1% during the forecast period (2025-2032).
The global preeclampsia diagnostics market is experiencing significant growth, driven by heightened awareness surrounding maternal health and the complexities of pregnancy-related complications. As preeclampsia, a serious hypertensive condition, poses substantial risks in obstetrics, the demand for precise and early diagnostic methods is escalating. Consequently, major market players are innovating diagnostic technologies aimed at improving early detection and management. Factors such as rising healthcare expenditures, enhancements in healthcare infrastructure in emerging markets, and the incorporation of advanced medical technologies in obstetric care are further propelling market expansion. However, high costs of sophisticated diagnostic methods and limited healthcare access in certain regions may pose challenges. With ongoing research into novel biomarkers and non-invasive diagnostics, the market is poised for continued advancements in the foreseeable future.
Top-down and bottom-up approaches were used to estimate and validate the size of the Preeclampsia Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Preeclampsia Diagnostics Market Segments Analysis
Global Preeclampsia Diagnostics Market is segmented by Test Type, Product, End-user and region. Based on Test Type, the market is segmented into Blood Tests, Urine Analysis and Others. Based on Product, the market is segmented into Instruments and Consumables. Based on End-user, the market is segmented into Hospitals, Specialty Clinics, Diagnostic Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Preeclampsia Diagnostics Market
The Preeclampsia Diagnostics market is driven by the challenges associated with accurately diagnosing the condition in pregnant women. A solitary increase in blood pressure is not a definitive indicator of preeclampsia, complicating the diagnosis process. Furthermore, many expectant mothers lack awareness of preeclampsia and its associated risks, which can lead to hypertension during pregnancy going undetected until it escalates, thereby restricting timely intervention opportunities. This gap in knowledge not only poses significant health risks to the women affected but also heightens the likelihood of increased infant mortality rates, underscoring the urgent need for effective diagnostic solutions and education.
Restraints in the Preeclampsia Diagnostics Market
The preeclampsia diagnostics market faces significant challenges due to the complexities involved in diagnosing the condition in pregnant women. A mere increase in blood pressure is not a definitive indicator of preeclampsia, making accurate identification difficult. Furthermore, a considerable number of expectant mothers lack knowledge about preeclampsia, which severely limits their understanding of the associated risks. As hypertension often goes undetected until more severe symptoms arise, this oversight restricts timely intervention options. The resultant unawareness poses considerable risks to maternal health and significantly heightens infant mortality rates, emphasizing the critical need for improved awareness and diagnostic methods in this area.
Market Trends of the Preeclampsia Diagnostics Market
The global preeclampsia diagnostics market is witnessing a significant trend towards early risk assessment for pregnant women, propelling the adoption of biomarker-based tests designed for the early detection of this condition. By focusing on specific biological markers, healthcare providers can more accurately identify potential preeclampsia cases, which enables timely interventions crucial for improving maternal and fetal health outcomes. This proactive diagnostic approach aligns with the overarching goals of healthcare systems to enhance maternal care and reduce the adverse effects of preeclampsia on pregnancies. As awareness and demand for early intervention grow, the market for innovative diagnostic solutions is expected to flourish in tandem.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement
Global Preeclampsia Diagnostics Market Size by Test Type & CAGR (2025-2032)
Market Overview
Blood Tests
Urine Analysis
Others
Global Preeclampsia Diagnostics Market Size by Product & CAGR (2025-2032)
Market Overview
Instruments
Consumables
Global Preeclampsia Diagnostics Market Size by End-user & CAGR (2025-2032)
Market Overview
Hospitals
Specialty Clinics
Diagnostic Centers
Others
Global Preeclampsia Diagnostics Market Size & CAGR (2025-2032)
North America (Test Type, Product, End-user)
US
Canada
Europe (Test Type, Product, End-user)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Test Type, Product, End-user)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Test Type, Product, End-user)
Brazil
Rest of Latin America
Middle East & Africa (Test Type, Product, End-user)
